Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy
- PMID: 15151592
- DOI: 10.1111/j.1440-1754.2004.00374.x
Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy
Abstract
Severe dystonia or status dystonicus is a life threatening disorder that develops in patients with both primary and secondary dystonia. We present the case of a 9-year-old boy with Hallervorden-Spatz disease (HVS) who developed status dystonicus, failing to respond to high dose oral therapy with multiple antidystonic agents. High dose intravenous sedating agents combined with endotracheal intubation and mechanical ventilation were required to control the spasms. Alleviation of the spasms was achieved by a combination of temporary intrathecal baclofen infusions and bilateral pallidotomy. Although it could be argued this is a situation where only palliative measures should be used, we believe a relatively aggressive approach was justified. It relieved the intense pain associated with the spasms and allowed the child to be discharged home without the prolonged stay in intensive care, morbidity and mortality, which characterize status dystonicus.
Comment in
-
Re: Status dystonicus and Hallervorden-Spatz disease.J Paediatr Child Health. 2004 Dec;40(12):721. doi: 10.1111/j.1440-1754.2004.00522.x. J Paediatr Child Health. 2004. PMID: 15569297 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources